Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M93,522Revenue (TTM) $M18,471Net Margin (%)18.2Altman Z-Score5.7
Enterprise Value $M94,956EPS (TTM) $2.0Operating Margin %19.2Piotroski F-Score5
P/E(ttm)28.0Beneish M-Score-2.0Pre-tax Margin (%)23.9Higher ROA y-yY
Price/Book6.010-y EBITDA Growth Rate %-3.5Quick Ratio1.3Cash flow > EarningsN
Price/Sales5.15-y EBITDA Growth Rate %-18.4Current Ratio1.5Lower Leverage y-yY
Price/Free Cash Flow104y-y EBITDA Growth Rate %62.7ROA % (ttm)10.4Higher Current Ratio y-yN
Dividend Yield %2.7PEG--ROE % (ttm)22.7Less Shares Outstanding y-yN
Payout Ratio %76.0Shares Outstanding M1,671ROIC % (ttm)15.8Gross Margin Increase y-yN

Gurus Latest Trades with BMY

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
BMYJulian Robertson 2016-09-30 Buy 5.11%$53.87 - $76.77
($64.24)
$ 55.96-13%New holding400,800
BMYVanguard Health Care Fund 2016-09-30 Add0.41%$53.87 - $76.77
($64.24)
$ 55.96-13%Add 7.84%48,804,797
BMYT Rowe Price Equity Income Fund 2016-09-30 Reduce-0.08%$53.87 - $76.77
($64.24)
$ 55.96-13%Reduce -6.77%3,100,000
BMYJoel Greenblatt 2016-09-30 Buy 0.06%$53.87 - $76.77
($64.24)
$ 55.96-13%New holding87,321
BMYMario Gabelli 2016-09-30 Reduce-0.03%$53.87 - $76.77
($64.24)
$ 55.96-13%Reduce -10.12%556,927
BMYRonald Muhlenkamp 2016-09-30 Reduce-0.03%$53.87 - $76.77
($64.24)
$ 55.96-13%Reduce -0.56%180,316
BMYRon Baron 2016-09-30 Reduce-0.02%$53.87 - $76.77
($64.24)
$ 55.96-13%Reduce -58.69%47,479
BMYKeeley Asset Management Corp 2016-09-30 Sold Out -0.01%$53.87 - $76.77
($64.24)
$ 55.96-13%Sold Out0
BMYKen Fisher 2016-09-30 Add$53.87 - $76.77
($64.24)
$ 55.96-13%Add 0.34%650,332
BMYDodge & Cox 2016-09-30 Reduce$53.87 - $76.77
($64.24)
$ 55.96-13%Reduce -0.28%71,958
BMYRonald Muhlenkamp 2016-06-30 Reduce-0.8%$63.88 - $74.29
($70.56)
$ 55.96-21%Reduce -14.54%181,340
BMYVanguard Health Care Fund 2016-06-30 Reduce-0.35%$63.88 - $74.29
($70.56)
$ 55.96-21%Reduce -5.23%45,257,309
BMYT Rowe Price Equity Income Fund 2016-06-30 Reduce-0.21%$63.88 - $74.29
($70.56)
$ 55.96-21%Reduce -17.52%3,325,000
BMYKeeley Asset Management Corp 2016-06-30 Buy 0.01%$63.88 - $74.29
($70.56)
$ 55.96-21%New holding2,960
BMYMario Gabelli 2016-06-30 Reduce-0.01%$63.88 - $74.29
($70.56)
$ 55.96-21%Reduce -5.26%619,627
BMYKen Fisher 2016-06-30 Add$63.88 - $74.29
($70.56)
$ 55.96-21%Add 1.89%648,107
BMYRon Baron 2016-06-30 Add$63.88 - $74.29
($70.56)
$ 55.96-21%Add 1.85%114,941
BMYFirst Eagle Investment 2016-06-30 Reduce$63.88 - $74.29
($70.56)
$ 55.96-21%Reduce -10.92%11,529
BMYDodge & Cox 2016-06-30 Reduce$63.88 - $74.29
($70.56)
$ 55.96-21%Reduce -1.77%72,158
BMYVanguard Health Care Fund 2016-03-31 Add0.21%$58.87 - $68.79
($63.1)
$ 55.96-11%Add 3.29%47,754,809
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

BMY is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


BMY: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
ANDREOTTI LAMBERTODirector 2016-09-08Sell21,600$56.87-1.6view
ANDREOTTI LAMBERTODirector 2016-08-25Sell23,200$59.17-5.43view
ANDREOTTI LAMBERTODirector 2016-07-08Sell23,200$74.45-24.84view
ANDREOTTI LAMBERTODirector 2016-06-28Sell23,200$72.14-22.43view
Elicker John ESVP, Public Affairs & IR 2016-06-14Sell11,820$72.69-23.02view
Bancroft Charles AEVP & CFO 2016-05-20Sell30,201$70.79-20.95view
Caldarella Joseph CSVP & Controller 2016-05-16Sell3,519$72.47-22.78view
LEUNG SANDRAEVP, General Counsel 2016-05-06Sell72,544$70.39-20.5view
ANDREOTTI LAMBERTODirector 2016-05-05Sell23,200$70.54-20.67view
Caforio GiovanniCEO 2016-05-03Sell34,594$71.31-21.53view

Press Releases about BMY :

Quarterly/Annual Reports about BMY:

News about BMY:

Articles On GuruFocus.com
Early Hedge Funder Julian Robertson Buys 2 Positions in 3rd Quarter Nov 14 2016 
52-Week Company Lows Nov 03 2016 
Baron Funds Comments on Bristol-Myers Squibb Co. Oct 25 2016 
52-Week Company Lows Oct 21 2016 
The Time Is Right to Pick Up Bristol-Myers Squibb Oct 17 2016 
The Pharmaceutical Sector Looks Attractive Oct 12 2016 
52-Week Company Lows Oct 07 2016 
Take a Look at Sanofi Oct 05 2016 
52-Week Company Lows Sep 29 2016 
52-Week Company Lows Sep 22 2016 

More From Other Websites
$50 Billion Quant Fund Is Making New Bets On These Stocks Dec 02 2016
What Do Analysts Recommend for Gilead Sciences Stock? Dec 02 2016
Bristol-Myers Squibb to Take Part at the Citi 2016 Global Healthcare Conference Nov 30 2016
Pharma Needs To Have A Sense Of Urgency Nov 30 2016
Hedge Funds Hate These 5 Huge Stocks -- Should You Sell Them? Nov 30 2016
Is Bristol-Myers Feeling Better? Not Really Nov 29 2016
How Was Bristol-Myers Squibb’s Profitability in 3Q16? Nov 29 2016
The Zacks Analyst Blog Highlights: Bristol-Myers, Google, Deere, Halliburton and American Airlines Nov 29 2016
How Did Bristol-Myers Squibb’s Blockbuster Oncology Drug Perform? Nov 28 2016
A Look At Billionaire Julian Robertson’s Top Dividend Picks Nov 25 2016
How Does Bristol-Myers Squibb’s Valuation Compare to Peers? Nov 25 2016
Final Trade: GM, BMY & more Nov 23 2016
Bristol-Myers Hodgkin Lymphoma Drug OKed in EU (BMY) Nov 23 2016
Bristol-Myers' Opdivo Gets EU Approval for Label Expansion Nov 23 2016
European Commission Approves Bristol-Myers Squibb’s Opdivo (nivolumab) for the Treatment of Adult... Nov 22 2016
European Commission Approves Bristol-Myers Squibb’s Opdivo (nivolumab) for the Treatment of Adult... Nov 22 2016
European Commission Approves Bristol-Myers Squibb’s Opdivo (nivolumab) for the Treatment of Adult... Nov 22 2016
Billionaire Julian Robertson Takes Out Huge SPY Hedge, Grows Bearish on Transportation Stocks Nov 21 2016

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)